All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
BBI / Brickell Biotech Inc
|
|
|
|
|
|
|
|
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TXMD / TherapeuticsMD, Inc.
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
RMTI / Rockwell Medical, Inc.
|
|
|
|
|
|
|
|
DVAX / Dynavax Technologies Corporation
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
SCMP / Sucampo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TROV / TrovaGene, Inc.
|
|
|
|
|
|
|
|
REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ZSPH / ZS Pharma, Inc.
|
|
|
|
|
|
|
|
JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TTOO / T2 Biosystems, Inc.
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
H03579101 / Auris Medical Holding Ltd
|
|
|
|
|
|
|
|
FWP / Forward Pharma A/S - ADR
|
|
|
|
|
|
|
|
KYTH / Kythera Biopharma
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
OREX / Orexigen Therapeutics, Inc.
|
|
|
|
|
|
|
|
KERX / Keryx Biopharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
WGBS / WaferGen Bio-Systems, Inc.
|
|
|
|
|
|
|
|
AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|